88 related articles for article (PubMed ID: 27273953)
1. The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience.
Luo H; Chen X; Zhang Q; Wang L; Qiao L; Liang N; Xie J; Yu X; Song M; Liu Z; Lv Y; Liu F; Tian Y; Cheng J; Deng G; Zhang J; Li XA; Zhang J
J BUON; 2016; 21(2):419-26. PubMed ID: 27273953
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.
Huang C; Zhu Y; Li Q; Zhang W; Liu H; Zhang W; Hu Y; Yuan Y; Liu M
Cancer Med; 2019 Jan; 8(1):28-39. PubMed ID: 30600600
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.
Du XX; Yu R; Wang ZF; Du DC; Liu QY; Wang RM; Kang SR; Yang H
Bosn J Basic Med Sci; 2019 May; 19(2):186-194. PubMed ID: 30877837
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
Song T; Du D; Zhang X; Fang M; Wu S
Dis Esophagus; 2017 Sep; 30(9):1-10. PubMed ID: 28859362
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
7. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.
Malaisrie SC; Hofstetter WL; Correa AM; Ajani JA; Komaki RR; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Wu TT; Swisher SG
Cancer; 2006 Sep; 107(5):967-74. PubMed ID: 16874819
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.
Wu CE; Lin YC; Hong JH; Chuang CK; Pang ST; Liaw CC
Anticancer Res; 2013 Jun; 33(6):2605-10. PubMed ID: 23749915
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
12. Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy.
Crvenkova S; Pesevska M
J BUON; 2015; 20(3):775-81. PubMed ID: 26214630
[TBL] [Abstract][Full Text] [Related]
13. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation.
Hatakenaka M; Yonezawa M; Nonoshita T; Nakamura K; Yabuuchi H; Shioyama Y; Nagao M; Matsuo Y; Kamitani T; Higo T; Nishikawa K; Setoguchi T; Honda H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e67-73. PubMed ID: 22365626
[TBL] [Abstract][Full Text] [Related]
14. Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate?
Lin JC; Liang WM; Jan JS; Jiang RS; Lin AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):156-64. PubMed ID: 15337551
[TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial.
Ji Y; Du X; Zhu W; Yang Y; Ma J; Zhang L; Li J; Tao H; Xia J; Yang H; Huang J; Bao Y; Du D; Liu D; Wang X; Li C; Yang X; Zeng M; Liu Z; Zheng W; Pu J; Chen J; Hu W; Li P; Wang J; Xu Y; Zheng X; Chen J; Wang W; Tao G; Cai J; Zhao J; Zhu J; Jiang M; Yan Y; Xu G; Bu S; Song B; Xie K; Huang S; Zheng Y; Sheng L; Lai X; Chen Y; Cheng L; Hu X; Ji W; Fang M; Kong Y; Yu X; Li H; Li R; Shi L; Shen W; Zhu C; Lv J; Huang R; He H; Chen M
JAMA Oncol; 2021 Oct; 7(10):1459-1466. PubMed ID: 34351356
[TBL] [Abstract][Full Text] [Related]
17. Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer.
Zhu ZF; Ma HL; Fan M; Bao Y; Zhuang TT; Chen M; Jiang GL; Fu XL
Technol Cancer Res Treat; 2014 Jun; 13(3):269-75. PubMed ID: 24066952
[TBL] [Abstract][Full Text] [Related]
18. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and benefit of concurrent chemoradiotherapy for elderly patients with uterine cervical cancer.
Nosaka K; Shibata K; Utsumi F; Yoshida K; Niimi K; Sekiya R; Suzuki S; Kajiyama H; Kikkawa F
Tumori; 2016 Dec; 102(6):600-605. PubMed ID: 27443893
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis.
Muller O; Mangiacapra F; Ntalianis A; Verhamme KM; Trana C; Hamilos M; Bartunek J; Vanderheyden M; Wyffels E; Heyndrickx GR; van Rooij FJ; Witteman JC; Hofman A; Wijns W; Barbato E; De Bruyne B
JACC Cardiovasc Interv; 2011 Nov; 4(11):1175-82. PubMed ID: 22035875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
